Salmonella typhi uses CFTR to enter intestinal epithelial cells

Nature

Volumn 393, Issue 6680, 1998, Pages 79-82

  Pier, Gerald B ^a   Grout, Martha ^a   Zaidi, Tanweer ^a   Meluleni, Gloria ^a   Mueschenborn, Simone S ^a   Banting, George ^b   Ratcliff, Rosemary ^c   Evans, Martin J ^d   Colledge, William H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; EPITHELIUM CELL; GENE MUTATION; GENE TRANSLOCATION; GENOTYPE; HUMAN; INTESTINE EPITHELIUM; INTESTINE MUCOSA; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SALMONELLA TYPHI;

ANIMALS; CELL LINE; COLON; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIUM; HUMANS; INTESTINAL MUCOSA; INTESTINES; JEJUNUM; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MUCOUS MEMBRANE; MUTATION; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TUMOR CELLS, CULTURED;

MURINAE; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0032492855     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/30006     Document Type: Article

References (25)

1. Bertranpetit, J. & Calafell, F. in Variation in the Human Genome (eds Chadwick, D. & Cardew, G.) 97-114 (Wiley, Chichester, 1996).
2. Jones, B. D. & Falkow, S. Salmonellosis: host immune responses and bacterial virulence determinants. Annu. Rev. Immunol. 14, 533-561 (1996).
3. Mills, S. D. & Finlay, B. B. Comparison of Salmonella typhi and Salmonella typhimurium invasion, intracellular growth and localization in cultured human epithelial cells. Microbiol. Path. 17, 409-423 (1994).
4. Olsen, J. C. et al. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum. Gene Ther. 3, 253-266 (1992).
5. Denning, G. M. et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764 (1992).
6. Pier, G. B. et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67 (1996).
7. Cheng, S. H. et al. Functional activation of the cystic fibrosis trafficking mutant ΔF508-CFTR by overexpression. Am. J. Physiol.-Lung Cell. Mol. Physiol. 12, L615-L624 (1995).
8. Pier, G. B., Grout, M. & Zaidi, T. S. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl Acad. Sci. USA 94, 12088-12093 (1997).
9. Walker, J., Watson, J., Holmes, C., Edelman, A. & Banting, G. Production and characterisation of monoclonal and polyclonal antibodies to different regions of the cystic fibrosis transmembrane conductance regulator (CFTR): detection of immunologically related proteins. J. Cell Sci. 108, 2433-2444 (1995).
10. Flotte, T. R. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl Acad. Sci. USA 90, 10613-10617 (1993).
11. Alpuche-Aranda, C. M., Berthiaume, E. P., Mock, B., Swanson, J. A. & Miller, S. I. Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Infect. Immun. 63, 4456-4462 (1995).
12. Ishibashi, Y. & Arai, T. A possible mechanism for host-specific pathogenesis of Salmonella serovars. Microbiol. Path. 21, 435-446 (1996).
13. Pascopella, L. et al. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect. Immun. 63, 4329-4335 (1995).
14. Jones, B. D., Ghori, N. & Falkow, S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180, 15-23 (1994).
15. Colledge, W. H. et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nature Genet. 10, 445-452 (1995).
16. Tsui, L. C. The cystic fibrosis transmembrane conductance regulator gene. Am. J. Respir. Crit. Care Med. 151, S47-S53 (1995).
17. Romeo, G., Devoto, M. & Galietta, L. J. V. Why is the cystic fibrosis gene so frequent? Human Genet. 84, 1-5 (1989).
18. Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C. & Stutts, M. J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266, 107-109 (1994).
19. Cuthbert, A. W., Halstead, J., Ratcliff, R., Colledge, W. H. & Evans, M. J. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J. Physiol. (Lond) 482, 449-454 (1995).
20. Pollitzer, R. Cholera (World Health Organization, Geneva, 1959).
21. Van Heyningen, W. E. & Seal, J. R. Cholera: The American Scientific Encounter, 1947-1980. 1-343 (Westview, Boulder, Colorado, 1983).
22. Fleiszig, S. M. J., Zaidi, T. S. & Pier, G. B. Psuedomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect. Immun. 63, 4072-4077 (1995).
23. Beatty, W. L. & Sansonetti, P. J. Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes. Infect. Immun. 65, 4395-4404 (1997).
24. O'Riordan, C. R. et al. Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells. J. Biol. Chem. 270, 17033-17043 (1995).
25. Rosner, B. in Fundamentals of Biostatistics 498-503 (Duxbury, Boston, Massachusetts, 1990).